JunZeJun Assists Teyi Pharmaceutical Group Co., Ltd. in the Non-Public Issuance of A-Share Stocks
On 9 November 2020, the application for the non-public issuance of A-share of Teyi Pharmaceutical Group Co., Ltd. ("Teyi Pharmaceutical"/“特一药业”, stock code: 002728) was approved by CSRC. Acting as PRC legal adviser, our Shenzhen Office assists Teyi Pharmaceutical in the Non-Public Issuance of A-Share Stocks and provides legal services throughout the project.
Teyi Pharmaceutical focuses on the pharmaceutical and health industry, mainly engaged in the R&D, production and sales of Chinese medicine, chemical agents and chemical raw materials. The core products of Teyi Pharmaceutical, Zhikebao Cough Tablet, is the exclusive variety in China. In 2009, its secret recipe was enlisted in Chinese Medicine's Cultural Heritage Protection List of Lingnan.
The non-public offering was jointly completed by Mr. Chen Youchun, Mr. Tang Duyuan, Mr. Chen Benrong, Mr. Wang Chengbin and Ms. Huang Yuan based in JunZeJun Shenzhen Office.